Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-06 Beever Charles Director Grant or award · Stock Option (right to buy) +3,537 3,537
2019-01-31 Beever Charles Director Purchase +10,000 $0.64 $6K 11,000
2018-06-28 Beever Charles Director Grant or award · Stock Option (right to buy) +39,742 39,742
2017-04-11 Beever Charles Director Grant or award · Stock Option (right to buy) +110,000 110,000
2016-06-09 Beever Charles Director Grant or award · Stock Option (right to buy) +225,000 225,000
2015-09-16 Beever Charles Director Grant or award · Stock Option (right to buy) +90,000 90,000
2014-06-09 Beever Charles Director Grant or award · Stock Option (right to buy) +60,000 60,000
2013-06-11 Beever Charles Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2012-06-18 Beever Charles Director Grant or award · Stock Options (right-to-buy) +20,000 20,000
2011-06-06 Beever Charles Director Grant or award · Stock Options (right-to-buy) +20,000 20,000

Page 1 of 1 · 10 trades